Most recent update: Sunday, April 29, 2018 - 14:56
You are here
News
Product launch
Medtronic has announced the launch of its Concerto three-dimensional (3D) detachable coil system intended to be used for embolizations in the peripheral arteries and veins, at CIRSE 2017, the annual...
Distribution agreement
VENITI have announced that Boston Scientific will distribute the Vici Venous Stent under a limited global distribution agreement. The terms of the agreement and specific regions and countries...
Acquistion
Cardinal Health has completed the acquisition of Medtronic's Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency business for US$6.1 billion. The Patient Care, Deep Vein Thrombosis and...
Product approval
The FDA has approved Bevyxxa (betrixaban, Portola Pharmaceuticals), the first and only anticoagulant for hospital and extended duration prophylaxis (35 to 42 days) of venous thromboembolism (VTE) in...
FDA warning
The type 2 diabetes prescription drug canagliflozin (brand names Invokana, Invokamet, Invokamet XR) appears to increase the risk of leg and foot amputations, according to the FDA. The FDA is...
- ‹ previous
- 2 of 5
- next ›
Product approval
HyperMed Imaging has received approval to apply the CE Mark for the HyperView medical imaging system allowing distribution of the product in Europe. HyperView is also currently distributed in the US...
Product launch
Smith & Nephew has launched the PICO 7 Single Use Negative Pressure Wound Therapy System (sNPWT) in Europe, the devices delivers a number of enhancements which benefit both the clinical...
pDVA System
LimFlow has completed enrolment of the original 10-patient cohort in the US feasibility study of the LimFlow Percutaneous Deep Vein Arterialization (pDVA) System. The company also announced that the...
Abre IDE study
Medtronic has initiated its investigational device exemption (IDE) study for the Abre venous self-expanding stent system. The ABRE IDE Study will evaluate the safety and effectiveness of the Abre...
